Home
>
US Stocks
>
Veracyte Inc
Veracyte Inc
VCYT

Veracyte Inc

$45.241.98%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
45.4
Today Low/High
44.86 / 45.55
52 Week Low/High
$28.82 / $86.03
Market Cap
$2.7B

Company Details

Veracyte is a global genomic diagnostics company that improves patient care by providing answers to clinical questions, informing diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. The company's growing menu of genomic tests leverage advances in genomic science and technology, enabling patients to avoid risky, costly diagnostic procedures and quicken time to appropriate treatment. The company's tests in lung cancer, prostate cancer, breast cancer, thyroid cancer, bladder cancer and idiopathic pulmonary fibrosis are available to patients and its lymphoma subtyping and renal cancer tests are in development. With Veracyte's exclusive global license to a best-in-class diagnostics instrument platform, the company is positioned to deliver its tests to patients worldwide. Veracyte is based in South San Francisco, California.
Organisation
Veracyte Inc
Headquaters
South San Francisco, California, US
Employees
320
Industry
Health Technology
CEO
Bonnie Anderson

Discover more

Frequently Asked Questions

What is Veracyte Inc share price today

Can Indians buy Veracyte Inc shares?

How can I buy Veracyte Inc shares from India?

Can Fractional shares of Veracyte Inc be purchased?

What are the documents required to start investing in Veracyte Inc stocks?

We are a SEBI registered investement advisor